Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with ATOMOXETINEEffective Shared Care Agreement (Esca) for Adhd Treatment • December 20th, 2018
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) withEffective Shared Care Agreement (Esca) for Adhd Treatment • December 20th, 2018
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) withEffective Shared Care Agreement (Esca) for Adhd Treatment • January 31st, 2019
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
Effective shared care agreement (ESCA) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with ATOMOXETINEEffective Shared Care Agreement (Esca) for Adhd Treatment • January 31st, 2019
This form must be completed by the hospital specialist/consultant (may include specialist nurse non-medical prescribers) and sent to the GP for approval. It must be signed by the GP and returned to the team before the patient is informed that the GP will prescribe the medication.
